United States Digital Therapeutics for Neurological Disorders Market 2025 | Growth Drivers, Trends & Forecast & Investment Opportunities

Market Size and Growth

Global Digital Therapeutics for Neurological Disorders Market reached US$ 246.94 million in 2024 and is expected to reach US$ 504.36 million by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.

Key Development:

United States: Recent Industry Developments

✅ In April 2025, Click Therapeutics received FDA marketing authorization for CT-132, the first prescription digital therapeutic for the preventive treatment of episodic migraine in adults, intended for adjunctive use alongside acute and/or other preventive migraine treatments.

✅ In August 2024, Otsuka Precision Health and Click Therapeutics launched RejoynTM, the first-and-only prescription digital therapeutic cleared by FDA for the adjunctive treatment of major depressive disorder (MDD) symptoms in adults age 22+, designed to help with cognitive control of emotion.

Japan: Recent Industry Developments

✅ In February 2025, Shionogi obtained domestic manufacturing and marketing approval in Japan for the digital therapeutic app ENDEAVORRIDE® (SDT-001) for pediatric ADHD, developed by Akili, as an adjunctive therapy.

✅ In February 2024, Shionogi submitted for marketing approval in Japan the digital therapeutic app SDT-001 (localized version of Akili's AKL-T01 / EndeavorRx) following positive Phase 3 trial results in children aged 6-17 with ADHD.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/digital-therapeutics-for-neurological-disorders-market?sb

Digital Therapeutics for Neurological Disorders are evidence-based software-driven interventions designed to prevent, manage, or treat conditions such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis. Delivered through apps, wearable devices, or platforms, they support cognitive training, symptom management, and patient engagement, offering personalized and non-invasive care alongside traditional therapies.

Recent Mergers and Acquisitions

✅ In May 2025, Relief Therapeutics announced a binding agreement to merge with NeuroX Group in a deal valued at CHF 1 billion for NeuroX (plus CHF 100 million for Relief). NeuroX had recently acquired MindMaze's digital neurotherapeutics assets, and the combined entity will create an AI-driven neurotherapeutics platform addressing conditions like stroke, Parkinson's, and dementia.

✅ In May 2025, Nerva completed the acquisition of key assets from Mahana Therapeutics. While not entirely neuro-specific, the acquisition strengthens Nerva's offerings in brain-gut behavioral therapy, overlapping with brain-body and neuro-behavioral health.

✅ In September 2024, Otsuka Pharmaceutical completed the acquisition of Jnana Therapeutics for about US$800 million upfront plus up to $325 million in milestone payments. Jnana's RAPID platform works on hard-to-drug targets relevant to neuroscience, expanding therapeutic opportunities for neurological disorders.

Key Players:

-> Akili, Inc., Click Therapeutics, Inc., BigHealth, Apple Inc., MindMaze Inc, NeuroPace, Inc., NeurologyToolKit, Matoph Labs e.U., Fullpower Technologies, Inc., Neybox Digital Ltd. and among others.

Growth Forecast Projected:

The Global Digital Therapeutics for Neurological Disorders Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Digital Therapeutics for Neurological Disorders Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-for-neurological-disorders-market

Key Segments:

By Product Type: Software Therapeutics, Wearable Devices

By Disease Type: Neurodegenerative Disorders, Mental Health Disorders, Stroke & Cerebrovascular Disorders, Sleep Disorders, Cognitive Disorders

By End-User: Hospitals, Specialty Clinics, Neuro-Rehabilitation Centers, Homecare Settings

Regional Analysis for Digital Therapeutics for Neurological Disorders Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Digital Therapeutics for Neurological Disorders producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Digital Therapeutics for Neurological Disorders revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-therapeutics-for-neurological-disorders-market?sb

FAQ

What is the current size of the Digital Therapeutics for Neurological Disorders Market?

A: In 2024, the Digital Therapeutics for Neurological Disorders Market was valued at US$ 246.94 million, reflecting its strong industry presence.

Q2: How large is the Digital Therapeutics for Neurological Disorders Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Digital Therapeutics for Neurological Disorders Market will grow to around US$ 504.36 million , demonstrating significant expansion.

Q3: What is the growth rate of the Digital Therapeutics for Neurological Disorders Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 8.3% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.